Find out how AI influences drug discovery, enabling earlier predictions and reducing the risks in clinical development.

The Drug Target Discovery Institute (Director Kim Dong-Hoon) of Korea University recently held its successful opening symposium. This symposium held lectures of leading global scholars in the fields ...

On January 9, 2026, the latest edition of Applied Artificial Intelligence for Drug Discovery was published online as a Springer Nature volume, spanning 27 chapters authored by leading international ...

Drug discovery startup Synfini Inc. said today it has closed on an $8.9 million expansion funding round led by JSL Health Capital, bringing its total amount raised to date to $53 million. The company ...

OutSee, a genomics and drug discovery company pioneering a unique AI-based predictive genomics approach to target discovery, ...

Illumina launched the Billion Cell Atlas to train AI on one billion single cells. AstraZeneca, Merck and Lilly are founding ...

Astrocytes, the predominant glial population in the human central nervous system, play crucial roles in neuroprotection, immunity, and homeostasis. However, when exposed to certain neuroinflammatory ...

Zhongyao Ma, PhD, holds a bachelor’s degree in biology from Shanghai Jiao Tong University and a PhD in genetics and developmental biology from the University of Georgia, U.S. His research focused on ...

This article and associated images are based on a poster originally authored by Paulina Chorobik, Maciej B. Olszewski, John Vincent and Kirsty Winn and presented at ELRIG Drug Discovery 2025 in ...

Learn how AI is transforming predictions of drug-induced liver injury and aiding drug development for safer therapeutics.